Key Takeaways
- Innodal received a No Objection Letter from USDA-FSIS for the use of INNEO™ in red meat and poultry.
- The determination allows both surface and in-product applications to control Listeria monocytogenes.
- INNEO™ previously received GRAS status from the FDA.
- The decision enables regulatory-compliant use within FSIS-regulated establishments.
Innodal Secures USDA-FSIS Regulatory Clearance For INNEO™
Innodal announced that the U.S. Department of Agriculture’s Food Safety and Inspection Service (USDA-FSIS) has issued a No Objection Letter confirming the acceptability of INNEO™ as a processing aid to control Listeria monocytogenes in red meat and poultry products.
The determination allows U.S. meat and poultry processors to use INNEO™ as both a surface treatment and within the food matrix of comminuted products. USDA-FSIS confirmed it has no objection to the intended use of INNEO™ as an antimicrobial intervention when applied on product surfaces or mixed directly into ready-to-eat formulations.
Innodal Expands Approved Applications Across Meat And Poultry Processing
INNEO™ is a natural antimicrobial processing aid based on a bacteriocin, a class of peptides known for targeted activity against Listeria monocytogenes. The product previously received Generally Recognized as Safe (GRAS) status from the U.S. Food and Drug Administration, and the FSIS No Objection Letter provides the final regulatory confirmation needed for use across red meat and poultry applications.
